7/29/2019 1:04:36 PM - Gapped up on the prior session hitting new 52-week and all-time highs. Reported earnings +12% on +6% sales revenues for the Jun '19 quarter. Prior quarters not strong and steady above the +25% minimum guideline (C criteria) and sub par sales revenues growth leaves concerns, fundamentally.
3/29/2019 1:20:16 PM - Consolidating near its 50 DMA line which acted as support. Stalled after hitting a new 52-week high on 3/01/19. Reported earnings +19% on +4% sales revenues for the Dec '18 quarter. Prior quarters not strong and steady above the +25% minimum guideline (C criteria) and sub par sales revenues growth leaves concerns, fundamentally.
12/17/2018 12:59:36 PM - Violated its 50 and 200 DMA lines following the previously noted "negative reversal" at its 52-week high on 12/03/18. Prior mid-day reports noted - "Reported earnings +50% on +4% sales revenues for the Sep '18 quarter. Prior quarters not strong and steady above the +25% minimum guideline (C criteria) and sub par sales revenues growth leaves concerns, fundamentally."
12/14/2018 12:40:17 PM - Down considerably today undercutting its 50 DMA line and testing its 200 DMA line again. Following a "negative reversal" at its 52-week high on 12/03/18 it tested its 200 DMA line then rebounded. Prior mid-day reports noted - "Reported earnings +50% on +4% sales revenues for the Sep '18 quarter. Prior quarters not strong and steady above the +25% minimum guideline (C criteria) and sub par sales revenues growth leaves concerns, fundamentally."
12/12/2018 1:02:11 PM - Following a "negative reversal" at its 52-week high on 12/03/18 it undercut its 50 DMA line and tested its 200 DMA line then rebounded. Prior mid-day reports noted - "Reported earnings +50% on +4% sales revenues for the Sep '18 quarter. Prior quarters not strong and steady above the +25% minimum guideline (C criteria) and sub par sales revenues growth leaves concerns, fundamentally."
12/10/2018 1:10:02 PM - Since a "negative reversal" at its 52-week high on 12/03/18 it slumped below its 50 DMA line. The 11/27/18 mid-day report noted - "Reported earnings +50% on +4% sales revenues for the Sep '18 quarter. Prior quarters not strong and steady above the +25% minimum guideline (C criteria) and sub par sales revenues growth leaves concerns, fundamentally."
11/27/2018 1:27:25 PM - Holding its ground since a "negative reversal" at its 52-week high when last noted with caution in the 11/19/18 mid-day report - "Reported earnings +50% on +4% sales revenues for the Sep '18 quarter. Prior quarters not strong and steady above the +25% minimum guideline (C criteria) and sub par sales revenues growth leaves concerns, fundamentally."
11/19/2018 12:42:58 PM - Hitting a new 52-week high today. Reported earnings +50% on +4% sales revenues for the Sep '18 quarter. Prior quarters not strong and steady above the +25% minimum guideline (C criteria) and sub par sales revenues growth leaves concerns, fundamentally.
10/30/2018 12:36:36 PM - Reported earnings +50% on +4% sales revenues for the Sep '18 quarter. Prior quarters not strong and steady above the +25% minimum guideline (C criteria) and sub par sales revenues growth leaves concerns, fundamentally.
10/26/2018 1:18:51 PM - Reported earnings +50% on +4% sales revenues for the Sep '18 quarter. Prior quarters not strong and steady above the +25% minimum guideline (C criteria) and sub par sales revenues growth leaves concerns, fundamentally.
10/22/2018 1:01:17 PM - Reported earnings +27% on +3% sales revenues for the Jun '18 quarter, but prior quarters were below the +25% minimum guideline (C criteria).
5/23/2016 12:36:57 PM - Reported earnings +11% on +10% sales revenues for the Mar '16 quarter, below the +25% minimum guideline (C criteria). Went through a deep consolidation since last noted with caution in the 9/11/15 mid-day report.
9/11/2015 12:54:34 PM - Slumped below its 50 DMA line from trading at its 52-week high when last noted with caution in the 7/31/15 mid-day report - "Reported earnings +19% on +11% sales revenues for the Jun '15 quarter, below the +25% minimum guideline (C criteria). The Medical - Hospitals group has some stocks recently showing leadership (L criteria).'
7/31/2015 1:30:11 PM - Gapped up today hitting another new 52-week high, rising from an orderly flat base. Reported earnings +19% on +11% sales revenues for the Jun '15 quarter, below the +25% minimum guideline (C criteria). The Medical - Hospitals group has some stocks recently showing leadership (L criteria).
6/25/2015 1:02:20 PM - Hitting a new 52-week high with today's big volume-driven gain, getting more extended from any sound base. It has not formed a sound base since last noted in the 5/28/15 mid-day report - "Found prompt support at its 50 DMA line during its prior consolidation. Reported earnings +31% on +15% sales revenues for the Mar '15 quarter, and 3 of the past 4 quarterly comparisons showed earnings increases of more than +25% (C criteria). The Medical - Hospitals group has some stocks recently showing leadership. Disciplined investors might watch for a new base to possibly be formed and noted in the weeks ahead."
5/28/2015 1:25:54 PM - Hit a new 52-week high with a big volume-driven gain and the 5/27/15 mid-day report noted - "Getting very extended from any sound base. Found prompt support at its 50 DMA line during its prior consolidation. Reported earnings +31% on +15% sales revenues for the Mar '15 quarter, and 3 of the past 4 quarterly comparisons showed earnings increases of more than +25% (C criteria). The Medical - Hospitals group has some stocks recently showing leadership. Disciplined investors might watch for a new base to possibly be formed and noted in the weeks ahead."
5/27/2015 1:00:07 PM - Hitting a new 52-week high with today's volume-driven gain, getting very extended from any sound base. Found prompt support at its 50 DMA line during its prior consolidation. Reported earnings +31% on +15% sales revenues for the Mar '15 quarter, and 3 of the past 4 quarterly comparisons showed earnings increases of more than +25% (C criteria). The Medical - Hospitals group has some stocks recently showing leadership. Disciplined investors might watch for a new base to possibly be formed and noted in the weeks ahead.
4/2/2015 1:25:35 PM - Pulled back from its 52-week high with a gap down and volume-driven loss on the prior session, yet found support at its 50 DMA line. Prior mid-day reports cautioned members - "Reported earnings +47% on +17% sales revenues for the Dec '14 quarter. Recent quarterly comparisons show encouraging sales revenues growth acceleration, but fundamental concerns remain. The Medical - Hospitals group has a Group Relative Strength Rating of 30, yet the group has some stocks recently showing leadership."
4/1/2015 1:00:59 PM - Pulling back from its 52-week high with a gap down and volume-driven loss today. Last noted in the 3/04/15 mid-day report with caution - "Reported earnings +47% on +17% sales revenues for the Dec '14 quarter. Recent quarterly comparisons show encouraging sales revenues growth acceleration, but fundamental concerns remain. The Medical - Hospitals group has a Group Relative Strength Rating of 30, yet the group has some stocks recently showing leadership."
3/4/2015 12:58:07 PM - Perched at its 52-week high today while adding to a spurt of gains with above average volume. Reported earnings +47% on +17% sales revenues for the Dec '14 quarter. Recent quarterly comparisons show encouraging sales revenues growth acceleration, but fundamental concerns remain. The Medical - Hospitals group has a Group Relative Strength Rating of 30, yet the group has some stocks recently showing leadership.
9/30/2014 1:18:39 PM - Violated its 50 DMA line and undercut its prior low with today's considerable loss. Prior mid-day reports repeatedly cautioned members - "Reported earnings +29% on +10% sales revenues for the Jun '14 quarter but fundamental concerns remain. Quarterly and annual earnings growth (C and A criteria) and sales revenues growth remain below the guidelines."
9/29/2014 12:35:28 PM - Finding support at its 50 DMA line. Prior mid-day reports cautioned members - "Reported earnings +29% on +10% sales revenues for the Jun '14 quarter but fundamental concerns remain. Quarterly and annual earnings growth (C and A criteria) and sales revenues growth remain below the guidelines."
9/15/2014 1:01:29 PM - Found support above its 50 DMA line during its consolidation after abruptly retreating from its 52-week high with recent volume-driven losses. The 9/04/14 mid-day report cautioned members - "Reported earnings +29% on +10% sales revenues for the Jun '14 quarter but fundamental concerns remain. Quarterly and annual earnings growth (C and A criteria) and sales revenues growth remain below the guidelines."
9/4/2014 12:57:08 PM - Slumping toward its 50 DMA line with today's 2nd consecutive volume-driven loss, abruptly retreating from its 52-week high. Reported earnings +29% on +10% sales revenues for the Jun '14 quarter but fundamental concerns remain. Quarterly and annual earnings growth (C and A criteria) and sales revenues growth remain below the guidelines.
7/28/2014 12:41:43 PM - Found recent support at its 50 DMA line and gapped up for a 2nd consecutive session today hitting new 52-week highs with considerable volume-driven gains. Reported earnings +29% on +10% sales revenues for the Jun '14 quarter but fundamental concerns remain. Undercut its 200 DMA line during its consolidation then rebounded since noted with caution in the 12/19/13 mid-day report - "Quarterly and annual earnings growth (C and A criteria) and sales revenues growth remain below the guidelines. It survived but failed to impress since last noted with caution in the 5/20/10 mid-day report - 'Recently rallied on M&A news it agreed to acquire Psychiatric Solutions (PSYS).'"
7/25/2014 12:50:00 PM - Found recent support at its 50 DMA line and gapped up today hitting a new 52-week high with a considerable volume-driven gain. Reported earnings +29% on +10% sales revenues for the June '14 quarter but fundamental concerns remain. Undercut its 200 DMA line during its consolidation then rebounded since noted with caution in the 12/19/13 mid-day report - "Quarterly and annual earnings growth (C and A criteria) and sales revenues growth remain below the guidelines. It survived but failed to impress since last noted with caution in the 5/20/10 mid-day report - 'Recently rallied on M&A news it agreed to acquire Psychiatric Solutions (PSYS).'"
7/22/2014 12:43:53 PM - Found support at its 50 DMA line and it is rallying near its 52-week high with today's considerable volume-driven gain. Reported earnings +11% on +5% sales revenues for the Mar '14 quarter. Undercut its 200 DMA line during its consolidation then rebounded since noted with caution in the 12/19/13 mid-day report - "Quarterly and annual earnings growth (C and A criteria) and sales revenues growth remain below the guidelines. It survived but failed to impress since last noted with caution in the 5/20/10 mid-day report - 'Recently rallied on M&A news it agreed to acquire Psychiatric Solutions (PSYS).'"
7/16/2014 1:00:45 PM - Gapped up today after finding support at its 50 DMA line, rallying near its 52-week high with today's considerable volume-driven gain. Reported earnings +11% on +5% sales revenues for the Mar '14 quarter. Undercut its 200 DMA line during its consolidation then rebounded since noted with caution in the 12/19/13 mid-day report - "Quarterly and annual earnings growth (C and A criteria) and sales revenues growth remain below the guidelines. It survived but failed to impress since last noted with caution in the 5/20/10 mid-day report - 'Recently rallied on M&A news it agreed to acquire Psychiatric Solutions (PSYS).'"
6/26/2014 1:03:18 PM - Retreating from its 52-week high with today's considerable loss. Reported earnings +11% on +5% sales revenues for the Mar '14 quarter. Undercut its 200 DMA line during its consolidation then rebounded since noted with caution in the 12/19/13 mid-day report - "Quarterly and annual earnings growth (C and A criteria) and sales revenues growth remain below the guidelines. It survived but failed to impress since last noted with caution in the 5/20/10 mid-day report - 'Recently rallied on M&A news it agreed to acquire Psychiatric Solutions (PSYS).'"
6/3/2014 1:12:02 PM - Hitting a new 52-week high today. Reported earnings +11% on +5% sales revenues for the Mar '14 quarter. Undercut its 200 DMA line during its consolidation then rebounded since last noted with caution in the 12/19/13 mid-day report - "Quarterly and annual earnings growth (C and A criteria) and sales revenues growth remain below the guidelines. It survived but failed to impress since last noted with caution in the 5/20/10 mid-day report - 'Recently rallied on M&A news it agreed to acquire Psychiatric Solutions (PSYS).'"
12/19/2013 1:40:37 PM - Slumping below its 50 DMA line today with a volume-driven loss. Reported earnings +21% on +8% sales revenues for the Sep '13 quarter. Made gradual progress since last noted in the 7/26/13 mid-day report with caution - "Quarterly and annual earnings growth (C and A criteria) and sales revenues growth remain below the guidelines. It survived but failed to impress since last noted with caution in the 5/20/10 mid-day report - 'Recently rallied on M&A news it agreed to acquire Psychiatric Solutions (PSYS).'"
7/26/2013 1:06:06 PM - Gapped up today, rebounding above its 50 DMA line. Reported earnings +7% on +6% sales revenues for the Jun '13 quarter. Prior mid-day reports cautioned - "Quarterly and annual earnings growth (C and A criteria) and sales revenues growth remain below the guidelines. It survived but failed to impress since last noted with caution in the 5/20/10 mid-day report - 'Recently rallied on M&A news it agreed to acquire Psychiatric Solutions (PSYS).'"
7/3/2013 11:42:17 AM - Gapped down today, slumping back below its 50 DMA line. Last noted in the 4/29/13 mid-day report with caution - "Quarterly and annual earnings growth (C and A criteria) and sales revenues growth remain below the guidelines. It survived but failed to impress since last noted with caution in the 5/20/10 mid-day report - 'Recently rallied on M&A news it agreed to acquire Psychiatric Solutions (PSYS).'"
4/29/2013 12:33:34 PM - Gapped up today and hit a new 52-week high. Found recent support at its 50 DMA line, an important support level. Noted in prior mid-day reports with caution - "Quarterly and annual earnings growth (C and A criteria) and sales revenues growth remain below the guidelines. It survived but failed to impress since last noted with caution in the 5/20/10 mid-day report - 'Recently rallied on M&A news it agreed to acquire Psychiatric Solutions (PSYS).'"
4/16/2013 12:52:06 PM - Retreated to its 50 DMA line, an important support level. Noted in prior mid-day reports with caution - "Quarterly and annual earnings growth (C and A criteria) and sales revenues growth remain below the guidelines. It survived but failed to impress since last noted with caution in the 5/20/10 mid-day report - 'Recently rallied on M&A news it agreed to acquire Psychiatric Solutions (PSYS).'"
4/10/2013 1:01:24 PM - Retreating from its 52-week high with above average volume behind recent losses while slumping toward its 50 DMA line. Made gradual upward progress since last noted in the 1/22/13 mid-day report with caution - "Quarterly and annual earnings growth (C and A criteria) and sales revenues growth remain below the guidelines. It survived but failed to impress since last noted with caution in the 5/20/10 mid-day report - 'Recently rallied on M&A news it agreed to acquire Psychiatric Solutions (PSYS).'"
1/22/2013 12:59:50 PM - Hitting another new 52-week high with today's 7th consecutive gain. Getting more extended from any sound base after additional gains with greater volume conviction since noted in the prior mid-day reports - "Quarterly and annual earnings growth (C and A criteria) and sales revenues growth remain below the guidelines. It survived but failed to impress since last noted with caution in the 5/20/10 mid-day report - 'Recently rallied on M&A news it agreed to acquire Psychiatric Solutions (PSYS).'"
1/17/2013 12:45:51 PM - Hitting a new 52-week high with today's 5th consecutive gain. Getting more extended from any sound base after additional gains with greater volume conviction since last noted in the 1/09/13 mid-day report - "Quarterly and annual earnings growth (C and A criteria) and sales revenues growth remain below the guidelines. It survived but failed to impress since last noted with caution in the 5/20/10 mid-day report - 'Recently rallied on M&A news it agreed to acquire Psychiatric Solutions (PSYS).'"
1/9/2013 12:50:18 PM - Perched near its 52-week high today after recently wedging up without great volume conviction. Quarterly and annual earnings growth (C and A criteria) and sales revenues growth remain below the guidelines. It survived but failed to impress since last noted with caution in the 5/20/10 mid-day report - " Recently rallied on M&A news it agreed to acquire Psychiatric Solutions (PSYS)."
5/20/2010 12:34:48 PM - Quarterly and annual earnings growth and sales revenues growth have been below guidelines. Recently rallied on M&A news it agreed to acquire Psychiatric Solutions (PSYS).
5/18/2010 1:02:58 PM - Quarterly and annual earnings growth and sales revenues growth have been below guidelines. Recently rallied on M&A news it agreed to acquire Psychiatric Solutions (PSYS).